The Technological Battlefield: Nexperia and the Sino-European Conflict
A company can be many things: a factory, a subsidiary, a patent portfolio, or a piece within a supply chain. In the ongoing technological war between China and Europe, it also represents a battleground. Nexperia is a prime example of this scenario. This isn’t merely about acquiring a semiconductor business based in the Netherlands and owned by Chinese Wingtech; it encapsulates broader issues concerning governance, legal authority, and the potential shift of industrial capabilities from one geopolitical center to another.
The New Demand
The latest legal maneuver originates from China. According to Reuters, Wingtech Technology and its subsidiary have initiated a lawsuit against Nexperia BV and five other entities in a Guangdong court, which has already accepted the case. They seek provisional compensation of 8 billion yuan (approximately $1.18 billion) for claimed economic losses. Furthermore, as highlighted by SCMP, Wingtech is demanding full control over Nexperia, reiterating the dispute’s implications for corporate governance and strategic oversight.
The Origin of the Crash
To grasp the context of this lawsuit, we must look back to September 2025. The Dutch government intervened in Nexperia, stripping Wingtech of effective control over the company due to concerns regarding the potential transfer of operations and intellectual property to China. Although this administrative decision was later revoked, the underlying issues remained. Wingtech argues that a parallel Dutch court ruling still restricts its control over Nexperia.
Nexperia’s Response
In light of Wingtech’s claims, Nexperia has downplayed the immediate significance of this judicial development. A company statement noted that it “has taken note of Wingtech’s announcement” and indicated that the corresponding court “has not opened the case to trial.” Nexperia expressed disappointment with Wingtech’s approach, suggesting a lack of interest in reaching a mutually beneficial resolution for all stakeholders, including Wingtech’s shareholders.
The Chinese Legal Route
The lawsuit initiated by Wingtech is not merely a business dispute; it is entangled within a politically charged legal framework. Wingtech is invoking China’s Foreign Sanctions Law, claiming damages from Nexperia’s executives for allegedly applying “discriminatory restrictive measures.” This legal pathway underscores the intertwining nature of business and politics, complicating the resolution of corporate disputes.
The Financial Blow
The ongoing conflict is also taking a toll on Wingtech’s finances. As reported by Reuters, the company recorded a net loss of 8.7 billion yuan in 2025, a significant increase from the 2.8 billion yuan loss the previous year. The adverse trend continued into the first quarter of 2026, during which Wingtech’s income plummeted by 94% after halting consolidation of foreign business results.
A Conflict Still Open
This lawsuit does not signal an end to the battle for Nexperia; rather, it prolongs it in a different domain. SCMP points out that both Beijing and The Hague have asserted that this dispute should be resolved “between the two companies without government interference.” This message, conveyed by Dutch Economy Minister Heleen Herbert after discussions with the Chinese ambassador, aims to minimize state involvement. However, the complexities of this case demonstrate the challenges of disentangling economic interests, legal matters, and industrial policy amid the competing influences of China and Europe.